View Author
Monninkhof, E.
( E. Monninkhof)
patient exacerbation antibody pneumococcal serotype copd patients vaccine pneumococcal colonization colonization disease conjugate valent study patient group serum polysaccharide serotype 6 b adult infection vaccination state increase level response sample sputum pneumoniae antibody levels culture titer concentration pneumococci coverage effect value group hazard ratio antibody titers development 23- presence exacerbation episode igg antibodies serum samples monoculture species table 2002. high-avidity 92 copd patients vaccine serotype strains episode cross-reactive serotypes pneumococcal capsular polysaccharides 115 pneumococcal sputum samples pathogen sputa conjugate vaccine high-avidity antibody titers conjugate vaccine serotypes van der palen result g /ml statens serum institute serotypes 19 f pneumococcal infection pneumococcal serotypes hazard capsular bacteria 11- ratio children wedzicha pneumococcal disease serotype distribution streptococcus pneumoniae sputum cultures risk factor
1 Most Recent Publications
|
Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease
(Article)
Bogaert, D. Valk, P. van der Ramdin, R. Sluijter, M. Monninkhof, E. Hendrix, R. Groot, R. de Hermans, P.W.M. |
2004-01-01
|